^
+ Follow PROFESS Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 568653
                    [Title] => The devil is content to let us profess Christianity as long as we do not practice it.
                    [Summary] => 

The devil is content to let us profess Christianity as long as we do not practice it.

[DatePublished] => 2010-04-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Word of the day [SectionUrl] => word-of-the-day [URL] => ) [1] => Array ( [ArticleID] => 226916 [Title] => First patient enrolled in stroke prevention trial [Summary] => The first patient has been enrolled in the Prevention Regimen For Effectively avoiding Second Strokes (PRoFESS) trial four weeks earlier than initially planned.

PRoFESS, the largest-ever secondary stroke prevention trial, will include a total of 15,500 patients in about 600 sites in more than 20 countries.

The principal investigator, Prof. Hans-Christoph Diener, randomized the first patient at the University of Essen in Germany.
[DatePublished] => 2003-11-06 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
PROFESS
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 568653
                    [Title] => The devil is content to let us profess Christianity as long as we do not practice it.
                    [Summary] => 

The devil is content to let us profess Christianity as long as we do not practice it.

[DatePublished] => 2010-04-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Word of the day [SectionUrl] => word-of-the-day [URL] => ) [1] => Array ( [ArticleID] => 226916 [Title] => First patient enrolled in stroke prevention trial [Summary] => The first patient has been enrolled in the Prevention Regimen For Effectively avoiding Second Strokes (PRoFESS) trial four weeks earlier than initially planned.

PRoFESS, the largest-ever secondary stroke prevention trial, will include a total of 15,500 patients in about 600 sites in more than 20 countries.

The principal investigator, Prof. Hans-Christoph Diener, randomized the first patient at the University of Essen in Germany.
[DatePublished] => 2003-11-06 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with